News | Radiation Therapy | September 19, 2017

Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting

Automated processes and actionable analytics help enhance patient care, increase productivity and reduce costs through easy-to-use operational dashboards and visual reports

Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting

September 19, 2017 — Elekta will highlight its Mosaiq Oncology Analytics (MOA) software solution at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego. MOA maximizes an electronic health record’s (EHR’s) potential to ensure clinics run at peak efficiency. MOA works seamlessly with single and multiple Mosaiq oncology information systems, either with Elekta Cloud Solutions or on premises, providing the actionable practice information needed to quickly assess and adapt to issues affecting quality of care, productivity and cost.

Elekta works with customers to tailor and validate the MOA dashboard to their specific needs, according to Andrew Wilson, vice president of global marketing for software solutions. Each MOA package is implemented so that it automatically pulls all the data that a specific client requires.

Other key benefits of MOSAIQ Oncology Analytics include:

  • Critical actionable information to help improve care for cancer patients, ensuring timely access to treatment by reducing wait times, eliminating bottlenecks and improving workflows; and
  • Efficient analysis of treatment patterns based on a variety of diagnostic indicators. These analyses readily identify trends and best practices that have the potential to improve patient outcomes. Periodic reviews of planned treatment doses, treatment plan variations, toxicity and survival help to enhance treatment efficacy.

ASTRO attendees are invited to visit Elekta to learn more about other new innovations and advanced technologies, including:

  • Magnetic resonance/radiation therapy (MR/RT), a new approach to radiation therapy in which magnetic resonance imaging (MRI) images are captured either prior to or during the fraction being delivered. Visualization of tumor position, shape, biology and surrounding tissue during radiation delivery may enable targeted adaption of the cancer treatment in real time, enabling critical advances in safety and efficacy. New technology will be presented that provides clinicians the ability to ‘see while you treat’ that may enable reductions in treatment margins around the tumor and thereby spare more healthy tissue. It may also allow clinicians to deliver a higher dose of radiation per fraction to the tumor, which may improve cancer treatment regimens and the efficiency of delivering radiation oncology care;
  • Leksell Gamma Knife Icon, which offers high-definition (HD) motion management and stereotactic cone beam computed tomography (CBCT) imaging allowing for precision intracranial radiosurgery with online dose adaptation, while also supporting instantaneous clinical decision-making and flexibility for frame-based and frameless immobilization;
  • High-definition dynamic radiosurgery (HDRS), a capability leveraging the core strengths of Versa HD linear accelerator and Monaco treatment planning system. Versa HD combines HDRS treatment capabilities and precision radiotherapy in a single platform, offering precision and speed to deliver stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments throughout the body in standard treatment time slots. Monaco powers more efficient high-definition planning with true Monte Carlo accuracy and advanced multi-criterial optimization; and
  • Elekta’s image-guided adaptive brachytherapy applicators and unified treatment planning and delivery platforms. This includes Venezia, a new gynecologic brachytherapy applicator designed to treat advanced cervical cancer, including disease with extra-cervical spread such as the parametrium and vagina.

For more information: www.elekta.com

Related Content

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares

This PET/CT shows metastasis of tumors, taken with the Philips TruFlight Select.

Feature | Radiation Oncology | January 31, 2018 | By Emily Clemons
Technological and scientific advances in radiation oncology are allowing practitioners to put patients first in...
Elekta and IBM Watson Health Bringing Artificial Intelligence to Oncology
News | Oncology Diagnostics | January 31, 2018
Elekta announced it is collaborating with IBM Watson Health to offer Watson for Oncology with Elekta’s cancer care...
Overlay Init